Alan Armstrong purchased GSK on March 30, 2026 | PolitAlpha
Alan Armstrong purchased GSK (Glaxosmithkline PLC) on Mar 30, 2026 with an estimated value between $15,000 and $50,000. This trade was filed under joint. The stock is currently down 4.3% from the trade price.